Mitragynine Conversion Using Oxone for Mild High-Purity Oxidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for converting mitragynine to 7-hydroxymitragynine are inefficient, requiring harsh conditions or yielding low conversion rates.
Innovation Solution
A controlled and reproducible method involving a reactor system with precise temperature and mixing controls, using sodium bicarbonate, oxone monopersulfate, and filtration, followed by phase separation chromatography, to optimize the conversion rate and purity of 7-hydroxymitragynine.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing conversion methods are used, then the conversion process can be completed, but the conversion rate is low and harsh conditions are required
Solution Approach 1:
The patent changes the reaction parameters by using a mild oxidizing agent (oxone monopersulfate) instead of harsh oxidants, controlling temperature at 0°C, and using specific solvents (sodium bicarbonate solution and water) to achieve high conversion rates without harsh conditions. This resolves the contradiction by optimizing reaction parameters to improve productivity while eliminating harmful conditions.
Solution Approach 2:
The patent uses oxone monopersulfate, a strong but selective oxidizing agent, to accelerate the oxidation of mitragynine to 7-hydroxymitragynine. This provides high conversion rates through efficient oxidation while maintaining milder conditions compared to traditional strong oxidants, resolving the contradiction between conversion rate and harsh conditions.
2Manufacturing precision
If existing conversion methods are used, then the conversion can proceed, but the purity of the product is low
Solution Approach 1:
The patent employs a multi-step extraction and purification process including filtration through a filtration membrane, liquid-liquid extraction with ethyl acetate, and phase separation chromatography. These steps selectively extract and separate 7-hydroxymitragynine from impurities and unreacted starting materials, achieving high purity (at least 95%) while maintaining good conversion efficiency.
Solution Approach 2:
The patent uses different purification techniques tailored to specific impurities: filtration for particulate matter, ethyl acetate extraction for organic impurities, and phase separation chromatography for closely related compounds. Each purification step targets specific quality aspects, achieving high overall purity while maintaining productivity.
3Manufacturing precision
If a reactor system with precise temperature and mixing controls is used, then the conversion rate and purity are optimized, but the device complexity increases
Solution Approach 1:
The patent uses a double jacketed reactor where temperature control is established beforehand through the jacket system, and mixing is pre-configured with the stirrer. These controls are built into the reactor design, allowing precise temperature and mixing control during the reaction without requiring complex additional equipment during operation.
Solution Approach 2:
The reactor system performs multiple functions: the double jacket provides both heating and cooling capabilities, the stirrer ensures uniform mixing, and the system accommodates the entire reaction and filtration process. This multi-functionality reduces the need for separate specialized equipment, managing device complexity while maintaining high manufacturing precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Achieves high-purity 7-hydroxymitragynine with at least 95% purity and minimal mitragynine residue, improving the efficiency and effectiveness of the conversion process.
Implementation Method 1
A second solution including sodium bicarbonate and water and a third solution including oxone monopersulfate and water are added to the first vessel including the first mitragynine solution. The first mitragynine solution is allowed to react with the second solution including sodium bicarbonate and water and the third solution including oxone monopersulfate and water to form a second mitragynine solution.
Implementation Method 2
The third mitragynine solution is transferred to an evaporator apparatus. At least some of the solvent is removed from the third mitragynine solution to form a fourth mitragynine solution by evaporating the solvent from the third mitragynine solution.
Implementation Method 3
The second mitragynine solution is passed through a filtration apparatus including a filtration membrane to form a third mitragynine solution captured in a second vessel.
Implementation Method 4
Phase separation chromatography using a phase separation column including at least one organic solvent is performed on the ethyl acetate extract enriched with 7-hydroxymitragynine. A high-purity 7-hydroxymitragynine product is collected from the phase separation column.
Data Source
AI summary
A method of converting mitragynine to 7-hydroxymitragynine includes dissolving a predetermined volume of mitragynine extract in a solvent to form a first mitragynine solution. The method includes adding a second solution including sodium bicarbonate and water and a third solution including oxone monopersulfate and water to the first vessel including the first mitragynine solution. The first mitragynine solution is allowed to react with the second solution including sodium bicarbonate and water and the third solution including oxone monopersulfate and water to form a second mitragynine solution including 7-hydroxymitragynine. The method includes separating the 7-hydroxymitragine from the second mitragynine solution and collecting a high-purity 7-hydroxymitragynine product.